Is cancerous inhibitor of protein phosphatase 2A ( CIP2A ) an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy?
CIP2A is an independent prognostic marker in patients with wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.
Objectively measured poorer sleep was associated with worse physical function. Future research is needed to identify the underlying mechanisms for the association between poor sleep and functional decline.